Clinical trial
A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in…
NCT00171704 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00171704 |
|---|---|
| Title | A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer |
| Official title | A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Collaborators | Danish Breast Cancer Cooperative Group University of Sheffield |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hormone Sensitive Resected Primary Breast Cancer in Postmenopausal Women |
| Intervention type | Drug |
| Interventions | Letrozole, Tamoxifen |
| Enrollment | 263 |
| Start date | Apr 1, 2005 |
| Primary completion | Mar 1, 2011 |
| Completion | Mar 1, 2011 |
| First posted | Sep 15, 2005 |
| Last update posted | Mar 3, 2017 |
| Countries | Denmark, United Kingdom |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: